2018
DOI: 10.1016/j.jpba.2017.10.027
|View full text |Cite|
|
Sign up to set email alerts
|

Absorption, liver first-pass effect, pharmacokinetics and tissue distribution of calycosin-7- O -ß- d -glucopyranoside (C7G) and its major active metabolite, calycosin, following oral administration of C7G in rats by LC–MS/MS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 10 publications
0
10
0
Order By: Relevance
“…Studies have shown that the drug concentration of CA in tissues is higher than that of systemic plasma, and the drug concentration in liver, kidney and heart is 212.1, 30.5 and 4.7 times that of systemic plasma. 29 The results of this experiment showed that the drug concentration of CA in normal rat brain tissue is about 2.54 times that in blood, while the drug concentration of CA in brain tissue of model rats is about 4.98 times that in blood, suggesting that CA can be used in the treatment of brain diseases, and cerebral ischemia-reperfusion injury can increase the distribution of CA in brain tissue.…”
Section: Resultsmentioning
confidence: 84%
See 2 more Smart Citations
“…Studies have shown that the drug concentration of CA in tissues is higher than that of systemic plasma, and the drug concentration in liver, kidney and heart is 212.1, 30.5 and 4.7 times that of systemic plasma. 29 The results of this experiment showed that the drug concentration of CA in normal rat brain tissue is about 2.54 times that in blood, while the drug concentration of CA in brain tissue of model rats is about 4.98 times that in blood, suggesting that CA can be used in the treatment of brain diseases, and cerebral ischemia-reperfusion injury can increase the distribution of CA in brain tissue.…”
Section: Resultsmentioning
confidence: 84%
“…As can be seen from Tables 5 and 6 , the rats in the model group demonstrated lower levels of C max blood , AUC 0-t blood , AUC 0-inf blood , and MRT brain and higher levels of CL blood and C max brain of CG compared to control group following the administration of HGWD, compared to the rats in the normal group, the C max blood was decreased, V blood and V brain of the CA were increased in model rats following the administration of HGWD. According to literature reports, 29 after intragastric administration of CA suspension (administration dose of 120 mg/kg), it was found that the plasma concentration–time curves of CA was double-peaked in the portal vein and systemic plasma, and the first peak time (T max ) appeared at 0.5 h or 1 h, the second T max appears at 4 h, and in this experiment, there is also a double peak in the plasma concentration–time curves of CA of the blood and brain tissues, the first T max appears around at 25 min, and the second T max appeared at about 55 min, indicating that the first T max of CA is due to the absorption of CA contained in the drug, and the second T max may be the formation of CA after the deglycosylation of CG in the intestine and intestinal cells. Studies have shown that the drug concentration of CA in tissues is higher than that of systemic plasma, and the drug concentration in liver, kidney and heart is 212.1, 30.5 and 4.7 times that of systemic plasma.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, calycosin was not detected in rat plasma, probably resulting from its strong phase II metabolism in liver. It was often found that high levels of phase II metabolites circulated in blood with trace amounts of aglycone in the pharmacokinetic profiles of isoflavones (Bai, Qu, Lu, Kano, & Yuan, ; Hosoda, Furuta, & Ishii, ; Qu et al, ; Tian et al, ; Wang, Gong, et al, ; Yuan et al, ; Zhang, Qi, Xu, Kano, & Yuan, ). Considerably different pharmacokinetics of CAG and calycosin have been published in the literature after rats were treated with TCM consisting of Huangqi (Liu et al, ; Liu et al, ; Shaw et al, ; Shi et al, ; Tao, Huang, Yang, Li, & Cai, ; Zeng et al, ; Zhang, Yang, Lin, & Hu, ).…”
Section: Resultsmentioning
confidence: 99%
“…This indicates that calycosin-7-O- β -glucoside may directly pass through the cell membrane in a prototype form without hydrolysis [ 69 ]. Using Caco-2 cells to study the absorption and transport characteristics of calycosin and its glucoside, it was found that calycosin and calycosin-7-O- β -glucoside are mainly absorbed in the form of passive diffusion, and the absorption process will not be affected by inhibitors of MATEs such as P-gp and MRP2 [ 69 , 70 ]. Calycosin can be metabolized in human liver microsomes to generate two glucuronides.…”
Section: Pharmacokinetics Of Calycosinmentioning
confidence: 99%